A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.
本发明揭示了一组苯甲
酰胺类化合物,可用于治疗神经退行性疾病。提供了制备这些化合物的方法。这些材料被制成口服或静脉注射的药物组合物,用于治疗患有帕
金森病等疾病的患者,这些疾病可以表现为中枢神经系统功能的逐渐丧失。这些化合物可以阻止或减缓功能逐渐丧失的进程。